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Background: There is no consensus on the most suitable treatment for tennis elbow but in 
the USA surgical intervention is increasing despite a lack of supportive research evidence. 
The aim of this systematic review was to provide a balanced update based on all relevant 
published RCTs to date. 
Methods An electronic search of MEDLINE, EMBASE, CINAHL, BNI, AMED, PsycINFO, HBE, 
HMIC, PubMed, TRIP, Dynamed Plus and The Cochrane Library, was complemented by hand 
searching. Risk of bias was assessed using the Cochrane Risk of Bias Tool and data was 
synthesised narratively, based on levels of evidence, due to heterogeneity. 
Results: 12 studies of poor methodological quality were included.  The available data 
suggest that surgical interventions for tennis elbow are not more effective than non-surgical 
and sham interventions. Surgical technique modifications may enhance effectiveness 
compared with traditional methods but have not been tested against placebo. 
Conclusions: Current research evidence suggests surgery for tennis elbow is no more 
effective than non-surgical treatment based on evidence with significant methodological 
limitations. Given the recalcitrant nature of tennis elbow for some patients, further research 
in the form of a high quality placebo-controlled surgical trial with additional conservative 
arm, is required to usefully inform clinical practice. 













Tennis elbow is the most common cause of lateral elbow pain and has been reported to 
have a point prevalence of 1 to 3%.1 Tennis elbow is characterised by pain near the lateral 
epicondyle that is aggravated by contraction of the extensor muscles, particularly when 
gripping an object.  It commonly affects adults of working age and can affect the individual’s 
ability to work and engage with other activities, including sport.2, 3 A study of worker’s 
compensation claims in Washington State between 1990 and 1998 found the average work 
sickness absence for elbow epicondylitis of 219 days with an average claim cost of 8099 US 
dollars.4  There is currently no established consensus on the most appropriate form of 
treatment for this condition although a treatment algorithm has been proposed but has not 
yet been evaluated.5  Many treatment options are available ranging from conservative 
measures such as physiotherapy, including exercise, manual therapy and strapping, 
injections of various substances, including corticosteroid and platelet rich plasma,  and 
surgical debridement.  Evidence suggests that although corticosteroid injections might offer 
short term pain relief, in the long term they lead to worse outcome than a wait-and-see 
approach and also negate the beneficial effects of therapeutic exercise treatments.5   
Given the recalcitrant nature of tennis elbow for some patients, surgical intervention might 
be offered to this group.  An increasing trend towards surgery is apparent in the USA with a 
rise in the proportion of patients with tennis elbow undergoing surgery from 1.1% in 2000-
2002 to 3.2% in 2009-2011 at the Mayo Clinic (Rochester, USA).6 Buchbinder et al 7 
conducted a systematic review of surgery for lateral elbow pain (that included tennis elbow) 
in 2002 and updated their review in 2011.8  The conclusions from both reviews were similar, 
describing the lack of evidence to support or refute surgery for this condition.  In particular 
there was a lack of high quality randomised controlled trials (RCTs) and specifically none 
that compared surgery to a placebo intervention.  Given the rising incidence of this surgery 
in the USA and in light of the findings of previous systematic reviews, the aim of this current 




A systematic review was conducted using a predetermined protocol registered on the 
PROSPERO database of systematic reviews (accessible via 
www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016050849) in accordance 
with the PRISMA-P statement.9 
 
 
 Search Strategy: 
An electronic search of MEDLINE, EMBASE, CINAHL, BNI, AMED, PsycINFO, HBE, HMIC, 
PubMed, TRIP database, The Cochrane Library , Dynamed Plus, NICE Guidance, CKS, SIGN 
and Specialist websites: including RGN, NIHR(National Institute for Health Research) was 
conducted by a medical librarian (BR) on March 8th & 9th 2017 using search terms detailed in 
Figure 1. An example search of the MEDLINE database is shown in Figure 2.  The database 
searches were supplemented by hand searches of abstracts presented at the British Elbow 
& Shoulder Society annual scientific meeting 2016 as these had yet to be published in the 
UK journal of Shoulder & Elbow and therefore yet to be indexed on PubMed.   
 




 [Figure 2:  Example search strategy using Medline database] 
 
Two reviewers (MB & CL) then independently screened titles and abstract before selecting 
full-text papers, where available, based on pre-defined inclusion criteria: 
 Adults diagnosed with Tennis Elbow 
 Any form of surgical intervention 
 Any form of comparator treatment including other forms of surgery, injections, 
physiotherapy, sham surgery or wait-and-see. 
 Randomised controlled trials only 
 English language 
 Primary outcomes: Patient reported outcome measures of pain and function 
 Secondary outcomes: Return to work, return to sport 
A third reviewer (AT) was available for arbitration in the event of disagreement but was not 
required.  The study selection process is detailed in Figure 3. 
 
[Figure 3: Study Selection Flowchart] 
 
 
 Data extraction: 
One reviewer (MB) extracted data in relation to study characteristics, participant 
characteristics, interventions and results before a second reviewer (CL) independently 
verified the findings.  The extracted data is presented in Table 1. 
Study Characteristics Participant 
Characteristics 
Interventions Results 
Dunkow et al 2004 10 
RCT comparing open 
Nirschl release 23 vs 
percutaneous tenotomy 
Conducted in the UK 
45 patients (47 
elbows)  
Age range 30-58 
22 male, 25 female 






Open Nirschl release 23 
with 3 drill holes into 
the lateral epicondyle 
(n=24) 
Percutaneous (1cm 




physiotherapy for both 
groups post-
operatively 
12-month follow up: 
Significant 
improvements in 
Disability of Arm 
Shoulder Hand (DASH) 
score (p=0.001) in both 
groups 
Patient satisfaction in 
favour of percutaneous 
group (p=0.012) 
Median return to work 
5 weeks in open group, 
2 weeks in 
percutaneous group.  
P=0.0001 in favour of 
percutaneous group 
Keizer et al 2002 11 
RCT pilot study 
comparing botulinum 
toxin (botox) injection vs 
open release (Hohmann 
method 24) 
Conducted in The 
Netherlands 
40 patients 
Mean age 42.8 (25-
72) 
19 male, 21 female 
Mean duration of 
symptoms 10.5 
months with 




36 patients had 
previous steroid 
30-40 units of botox 
injected into the 
extensor carpi radialis 
brevis (ECRB) (n=20).  8 
patients given a 
second injection due to 
limited effect. 
Hohmann technique of 
open release 24 of ECRB 
(n=20) followed by 
sling for 2 weeks 
 
Outcomes measured 
by modified Verhaar 
score 25: 
4 patients in the botox 
group underwent open 
surgery due to failed 
response.  Outcomes 
for these patients at 24 
months were 1 good, 1 
fair, 2 poor. 
Main results at 24 
months: 
Botox: 11/16 excellent 
result, 4/16 good, 1/16 
injections fair. 
Open surgery: 14/20 
excellent result, 3/20 
good, 3/20 poor. 
Overall no significant 
differences reported in 
pain or range of 
motion at 3, 6, 12 or 
24 months. 
Sick leave in favour of 
surgery group at 3 
months (p=0.01) but 
no difference at 6, 12, 
24 months 
Khashaba 2001 12 
RCT comparing Nirschl 
technique of open 
release 23 with or without 
drilling the bone of the 
anterolateral humeral 
condyle 
Conducted in the UK 
18 patients (23 
elbows) 
Aged over 18 
Failed to improve 
with rest and 
physiotherapy 
Temporary (<6 




Nirschl open release 23 
including 3 drill holes 
into the lateral 
epicondyle (n=9 
patients but number of 
elbows not stated) 
Nirschl open release 23 
without the drilling 
component (n=9 but 
number of elbows not 
stated) 
Mean wrist extension 
power improvement  
using AK-7000 
extensionometer at 6 
months: drilled 5.2kg, 
non-drilled 6.5kg 
Mean improvement in 
pain Visual Analogue 
Scale (VAS) 3-6 
months: drilled 4.6cm, 
non-drilled 6.8cm 
Kroslak & Murrell 2017 13 
RCT comparing open 
Nirschl release 23 vs sham 
surgery (skin incision 
only) 
Conducted in Australia 
Conference abstract only 
26 patients 
Groups matched for 
age, gender, hand 
dominance, duration 
of symptoms 
Chronic tennis elbow 




Nirschl open release 23 
(n=13) 
Sham surgery involving 
skin excision and 
exposure to level of 
ECRB tendon (n=13) 
 
Both groups improved 
subjective outcomes at 
6 and 12 months 
(p<0.01). 
Both groups improved 
tenderness, 
pronation/supination 
range, grip strength 
and ORI-TETS score 26 
at 6 months (p<0.05). 
No differences 
between groups in any 
measure at any time 
point. 
Study stopped early 
due to lack of 
difference between 
groups. 
Leiter et al 2016 14 
RCT comparing open vs 
arthroscopic release 
Conducted in Canada 
Conference abstract only 
71 patients 
Aged over 16 
Open group: mean 
age 47.1; 19 male, 
15 female 
Arthroscopic group: 
mean age 45.0; 21 
male, 13 female 
Failed to improve 
with 6 months 
conservative 
treatment 
Open tennis elbow 
release (n=34) 
Arthroscopic tennis 
elbow release (n=34) 
? Some individuals had 
bilateral surgery due to 
discrepancy in total 
number of patients 
No difference in pain 
VAS, DASH score or 
grip power between 
groups at any time 
point up to 12 months. 
17/34 met the 
minimally clinically 
important difference 
(MCID) in DASH score 
in the open group and 
19/34 in the 
arthroscopic group. 
Leppilahti et al 2001 15 
RCT comparing open 
posterior interosseous 
nerve decompression vs 
open extensor carpi 
radialis brevis tenotomy 
Conducted in Finland 
26 patients (28 
elbows) 
Nerve group: mean 
age 42 (33-50); 6 
male, 7 female 
Tenotomy group: 
mean age 41 (30-
52); 7 male, 7 female 
Mean symptom 





mean number of 
steroid injections 4.5 
Open decompression 




tenotomy of the ECRB 
(n=14) 
Mean follow up 31 
months (22-48). 
No significant 
difference in grip 
strength between 
groups. 
Subjective pain relief: 
Nerve group: 3 
excellent, 4 good, 2 
fair, 5 poor. 
Tenotomy group: 2 
excellent, 4 good, 5 
fair, 3 poor. 
Patients undergoing 
repeat surgery due to 
poor outcome: nerve 
group 4, tenotomy 
group 3. 
Meknas et al 2008 16 
RCT comparing 
radiofrequency 
microtenotomy vs open 
surgical release & repair 
Conducted in Norway 
24 patients 
13 male, 11 female 
Open surgery: mean 





mean age 46.7 (30-
64).  Mean symptom 
duration 22 months 
All patients had 
minimum symptoms 
12 months with 
failed conservative 
treatment including 
3 months of 
physiotherapy and 
at least 3 steroid 
injections 
Open surgical release 
using modified Nirschl 
technique 23 (n=11) 
Open 3cm exposure of 
extensor tendon with 
microtenotomy using a 
radiofrequency device 
to a depth of 3-5mm in 
3-6 areas (n=13) 
No difference in pain 
VAS between groups at 
3, 6, 12 weeks or 10-18 
months. 
Both groups had 
significant pain 
reduction from 6 
weeks onward (p<0.04 
open, p<0.001 
microtenotomy) 
23/24 patients had 
reduced pain at 10-18 
months (p<0.05) 
No difference in grip 
strength between 
groups at 12 weeks 
and no difference to 
contralateral side. 
No difference in Mayo 
Elbow Performance 
Score (MEPS) between 
groups at 12 weeks but 
significantly better 




Meknas et al 2013 17 
RCT comparing 
radiofrequency 
microtenotomy vs open 
surgical release & repair 
Conducted in Norway 
24 patients 
13 male, 11 female 
Open surgery: mean 





mean age 46.7 (30-
64).  Mean symptom 
duration 22 months 
Open surgical release 
using modified Nirschl 
technique 23 (n=11) 
Open 3cm exposure of 
extensor tendon with 
microtenotomy using a 
radiofrequency device 
to a depth of 3-5mm in 
3-6 areas (n=13) 
 
 
5-7 year follow up: 
1 patient had died due 
to unrelated causes.   
1 patient in the 
microtenotomy group 
had revision open 
surgery. 
Improved pain VAS in 
both groups (p<0.005) 
but no differences 
between groups. 
All patients had 
minimum symptoms 
12 months with 
failed conservative 
treatment including 
3 months of 
physiotherapy and 
at least 3 steroid 
injections 
No difference in grip 
strength between 
groups. 
Improved MEPS in 
both groups (p<0.01) 
but no difference 
between groups.  
Monto 2014 18 
RCT comparing Nirschl 
open release 23 and 
repair with or without 
suture anchors 
Conducted in the USA 
60 patients with 
positive MRI findings 
of Tennis Elbow. 
No anchor group: 
mean age 48.2 (30-
61); 16 male, 14 
female. 
Anchor group: mean 
age 49.3 (30-62); 18 
male, 12 female. 
Failed 6 months of 
conservative 
treatment including 






Anchor group 10.4 
months 
No anchor group 8.9 
months 
Elbow arthroscopy and 
debridement followed 
by Nirschl open 
release23 (n=30) 
Elbow arthroscopy 
followed by open 
debridement, 
decortication and 
suture reattachment of 
ECRB tendon to the 
lateral epicondyle 
using two polyether 
ether ketone (PEEK) 
bone anchors (n=30) 
Improvements seen in 
both groups but no 
statistical analysis from 
baseline 
measurements. 
3 patient outcomes in 
the no anchor group 
regarded as clinical 
failures.  No failures in 
suture anchor group. 
Between group 
improvements in MEPS 
and DASH score in 
favour of suture 
anchor group at 1, 2, 3, 
6, 12 months 
(p=0.001). 
 
Morgan et al 2016 19 
RCT comparing platelet-
rich plasma injection vs 
surgical release 
Conducted in the UK 
92 patients but 11 
lost to follow up. 
Mean age 47 
34 male, 47 female 
Minimum symptom 
Platelet-rich plasma 
(PRP) injection using a 
peppering technique 
(n=42) 
Surgical release (n=39) 
13/42 of PRP group 
requested surgery 
between 2-6 months 
after injection 
1/39 surgical patients 
subsequently had a 





difference in Patient 
Reported Tennis Elbow 
Evaluation (PRTEE) or 
DASH scores between 
groups up to 12 
months. 








(ESWT) vs percutaneous 
tenotomy 
Conducted in Egypt 
62 patients but 6 
lost to follow up. 
ESWT group: mean 
age 40.14 (23-60); 
15 male, 14 female. 
Tenotomy group: 
mean age 39.26 (22-
59); 18 male, 9 
female 
Minimum symptom 





steroid injection  
ESWT to the common 
extensor origin at the 
point of maximum pain 
with a dose of 324.25 
joules (n=29) 
Grundberg & Dobson 
technique 27 of 
percutaneous common 
extensor origin release 
with back-slab plaster  




groups in any 
measures at any time 
up to 12 months. 
VAS improved (p<0.01) 
at all time points in 
both groups for 
pressure pain up to 12 
months. 
VAS improved (p<0.01) 
at 3 and 6 weeks in 
both groups for rest 
pain. 
VAS improved (p<0.01) 
for night pain in ESWT 
group up to 12 months 
and tenotomy group 
up to 12 weeks. 
Yan et al 2009 21 
RCT comparing open vs 
arthroscopic Nirschl 
release 23 
Conducted in China 
English abstract only 
26 patients (28 
elbows) 
Mean duration of 
conservative care 23 
months (4-60) 
Open Nirschl release 23 
(n=13) 
Arthroscopic Nirschl 23  
release (n=15) 
Mean follow up 17.4 
months (4-32) 
No difference between 
groups in pain VAS at 
rest or with daily living, 
return to work/sport 
or satisfaction. 
Full text only available in 
Chinese language 
Significant difference 
in pain VAS at work & 
sports and MEPS in 
favour of open group. 
Open group: 100% 
good or excellent 
results. 
Arthroscopic group: 





Risk of Bias Assessment: 
Risk of bias assessment was conducted independently by two reviewers (MB & CL) using the 
Cochrane Risk of Bias Assessment Tool.28 The process rates each study in terms of high risk, 
unclear risk and low risk of bias within seven domains based on published guidance.28 Any 
discrepancies between reviewers were then discussed and resolved.   A third reviewer (AT) 
was available to cast a decisive vote, however this was not required.  The outcomes were 
compiled using Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: 
The Nordic Cochrane Centre, The Cochrane Collaboration, 2014; and used to generate the 
risk of bias charts (Figures 4 & 5). 
 
[Figure 4:  Risk of bias across domains] 
 
 [Figure 5:  Risk of bias per study] 
 
Due to heterogeneity across the retrieved studies in relation to surgical interventions and 
measures of clinical outcome, a narrative synthesis based on levels of evidence was 
undertaken.29 This rating system, displayed in table 2, is used to summarise the results in 
which the quality and outcomes of individual studies are taken into account. 
 
Strong Evidence Consistent findings in multiple high quality RCTs (n> 2) 
Moderate Evidence Consistent findings among multiple lower quality RCTs and/ or 1 higher quality RCT 
Limited Evidence Only one relevant low quality RCT 
Conflicting evidence Inconsistent findings amongst multiple RCTs 
No evidence from trials No RCTs 
Table 2:  Levels of Evidence 
 
RESULTS: 
124 abstracts were identified using database searches plus one additional paper from hand 
searching.  After screening out duplicates and those that did not meet the inclusion criteria, 
13 abstracts remained.  Nine of these were available in full text versions plus three as 
conference abstracts only and one with an English translation abstract but full text in 
Chinese language.  One full text was excluded as it was a protocol for a randomised 
controlled trial that had not yet been completed.22 
The remaining 12 studies were assessed for risk of bias and the results are shown in figures 
4 & 5.  The two studies by Meknas et al 16, 17 investigated the same cohort of patients over 
different time points so details from each paper were merged for the assessment.  It is 
notable that the risk of bias in all studies was unclear-to-high in five out of seven domains. 
In total, the included studies investigated 490 patients (501 elbows).  Four studies compared 
a surgical intervention versus non-surgical intervention (including sham surgery). 11, 13, 19, 20 
We acknowledge that sham surgery still involves a surgical SKIN incision however we regard 
this as a non-surgical intervention or placebo as the area of pathology (i.e. the extensor 
tendons) are subject to no direct intervention and  may not produce the same physiological 
changes. Two studies compared open versus arthroscopic surgical release.14, 21 Two studies 
of the same patient group over different time periods investigated radiofrequency 
microtenotomy versus open release.16, 17 Two studies compared the Nirschl surgical 
technique23 versus a modified technique.12, 18 The remaining single studies compared open 
release versus a percutaneous mini-open technique;10 and open release versus posterior 
interosseous nerve decompression.15 In studies where interventions were similar, 
heterogeneity in the terms of outcome measures precluded synthesis using a meta-analysis. 
There is moderate evidence (four relevant low quality RCTs) that surgery, such as the Nirschl 
technique of open release 23, is not superior to non-surgical interventions, including Botox 
injection, shockwave therapy, platelet-rich plasma injection and sham surgery, up to 12 
months in terms of the primary outcome measure of pain and function including subjective 
pain measures, modified Verhaar score, PRTEE and DASH scores.11, 13, 19, 20   The sham 
surgery trial 13 was terminated prematurely as a result. 
There is conflicting evidence (inconsistent findings amongst two RCTs) in relation to the 
effectiveness of open versus arthroscopic surgical release. 14, 21   One RCT found no 
significant differences between groups in VAS, DASH score or grip power at any time up to 
12 months14 and the other RCT reported in favour of open surgery based on Mayo Elbow 
Performance Score and a sub-set of outcomes measuring pain VAS at work and during 
sport.21 
There is limited evidence (one relevant low quality RCT) suggesting no difference between 
radiofrequency microtenotomy and open surgical release in the short, medium or long term 
in relation to pain and function. 16, 17 
There is limited evidence (two low quality RCTs 12, 18) in relation to the effectiveness of the 
standard Nirschl release compared to a modified surgical technique. 12, 18   Both found in 
favour of the modified technique: one RCT reported in favour of ECRB tendon repair using 
suture anchors at 12 months18 and another in favour of not drilling the epicondylar bone at 
six months.12  
There is limited evidence (one relevant low quality RCT) suggesting no difference between 
mini-open percutaneous release and traditional open release in terms of DASH score at 12 
months but a faster return to activity in the minimally invasive group was reported with 
median return to work of five weeks in the open group compared to 2 weeks in the 
percutaneous group (p=0.0001).10   
There is limited evidence (one relevant low quality RCT) suggesting no difference between 
traditional open release and posterior interosseous nerve decompression at mean follow up 
of 31 months in terms of pain, grip strength and revision surgery.15 
 
DISCUSSION: 
The findings of this systematic review suggest that surgical interventions for tennis elbow 
are not more effective than non-surgical and sham interventions. Procedural modifications 
may enhance the comparative effectiveness of surgical interventions but have not been 
compared against placebo interventions. These findings, however, are based on a body of 
evidence with significant methodological limitations.  
In keeping with previous systematic reviews 7, 8 these findings raise questions in relation to 
the effectiveness of surgery for tennis elbow and, considering risks and costs, whether non-
surgical interventions might be the current treatment of choice for this disorder. The 
question of how best to manage patients with persistent symptoms despite a period of 
failed conservative treatment still remains.  Surgery has traditionally been regarded as being 
at the top of the treatment hierarchy but our findings suggest that it may not be any more 
effective than a further course of non-surgical treatment. However, this review also 
highlights the significant limitations in relation to the research evidence underpinning 
surgery for tennis elbow. Many of the included studies recruited small sample sizes with 
high likelihood of Type II error, had questionable or unclear methods of randomisation, 
allocation concealment and a lack of blinding of participants and outcome assessment.  
These significant methodological limitations give rise to a high risk of bias in the studies 
completed to date. Furthermore, there was a wide variation in the methods of outcome 
assessment used meaning that meaningful data synthesis, that might counteract some of 
the limitations of the individual trials, is compromised.  Patient expectations have also not 
been considered in this study and evidence from rotator cuff surgery suggests that patient 
expectation of a surgical solution is the greatest predictor of whether conservative 
management fails.30 
There seems adequate justification to propose further research in light of the significant 
methodological limitations of the current body of evidence, given the recalcitrant nature of 
tennis elbow for some patients and recognising that many do not resolve adequately with 
current treatment interventions.  There is a clear indication for a high-quality, adequately 
powered RCT comparing surgical to sham surgical intervention including validated measures 
of patient reported pain and function. Unfortunately the reported sham study was 
terminated early due to a lack of difference in outcomes between groups but the small 
numbers of recruits mean that this was underpowered and mean that the conclusion that 
surgery is no more effective than placebo cannot be strongly supported.13  Despite the 
challenges associated with sham-controlled surgical trials,31 precedent has been set in the 
upper limb including a sham-controlled surgical trial investigating superior labral tears in the 
shoulder32 and a current UK trial comparing arthroscopic shoulder decompression surgery 
to a sham procedure33, thus highlighting the feasibility of a larger trial. 
 
CONCLUSIONS: 
The findings of this systematic review suggest that surgical interventions for tennis elbow 
are not more effective than non-surgical or sham interventions for patients who have 
already undergone a course of conservative treatment. Caution is warranted though 
because these findings are based on a body of evidence with significant methodological 
limitations.  There is now a clear indication for a high-quality, adequately powered RCT 
comparing surgical to sham surgical intervention, including validated measures of patient 
reported pain and function to inform future clinical practice.  The inclusion of a third 
treatment arm in the form of a credible conservative intervention, e.g. a structured 
physiotherapy package or a wait-and-see approach, would allow conclusions to be drawn 
regarding the most efficient and effective treatment strategy. 
Funding: No funding received 
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